The Single-Use Bioreactors Market is projected to grow significantly from USD 5.43 billion in 2026 to USD 9.58 billion by 2031, reflecting a compound annual growth rate (CAGR) of 12.0%. Key trends driving this market include increased outsourcing by Contract Development and Manufacturing Organizations (CDMOs), enhanced adoption of continuous and perfusion processing, and a rising focus on cell and gene therapies. North America currently dominates the market, accounting for 37.9% of the share in 2025, spurred by strong investments in biotechnology and advanced manufacturing technologies. The demand for single-use systems is expected to rise, driven by their efficiency in biomanufacturing and lower contamination risks.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.prnewswire.com/news-releases/single-use-bioreactors-market-worth-9-58-billion-by-2031—exclusive-report-by-marketsandmarkets-302833098.html
